Wong, P-PYeoh, C CAhmad, A SChelala, CGillett, CSpeirs, VJones, J LHurst, H C2018-07-262018-07-262014-09-11Wong, P-P, Yeoh, C C, Ahmad, A S, Chelala, C, Gillett, C, Speirs, V, Jones, J L & Hurst, H C 2014, 'Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer', Oncogene, vol. 33, no. 37, pp. 4579-4588. https://doi.org/10.1038/onc.2014.450950-9232PubMedCentral: PMC4162461ORCID: /0000-0002-0602-4666/work/72631280http://hdl.handle.net/2164/10811We are grateful to our colleagues Andrew Clear, Keyur Trivedi and Abeer Shaaban for technical assistance with the TMA for the BLT and Leeds cases, respectively, Dr Yaohe Wang for help with scoring the Immunohistochemistry study, Ian Hart and Steven Robinson for invaluable advice and help with the xenograft study and to Richard Grose for useful comments on the manuscript. We thank Tracey Chapman for expert handling of the Affymetrix arrays and Simak Ali, Dennis McCance and Hinrich Gronemeyer for the generous provision of reagents. This work was funded by Cancer Research UK and Barts and the London Charity.103232207engSDG 3 - Good Health and Well-beingBreast cancerCancer therapeutic resistanceTumor immunologyRC0254 Neoplasms. Tumors. Oncology (including Cancer)Cancer Research UKSupplementary DataRC0254Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancerJournal article10.1038/onc.2014.453337